IASIC Speaker Series Presents Marijuana Biology: Does Potency Matter?

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed, organized, and guided by doctors.

Presented By: Bertha Madras, PhD
Date:Thursday, January 6, 2022
Time: 4:00PM Eastern/1:00PM Pacific
Price: FREE

The endocannabinoid system in the body is a primary target of THC, the key cannabinoid in marijuana. What is the endocannabinoid signaling system? Where is it localized? What are its functions? How do THC and endocannabinoids act? What are phytocannabinoids (compounds made by plants)? What are THC actions in the body? (receptor targets in the brain, peripheral tissues) Do THC and opioid signaling systems crosstalk? Do actions by THC (plant-derived) or endocannabinoids (made by the brain) differ? Does THC affect neurodevelopment? Medical marijuana and recreational marijuana; do they differ? What are the consequences of THC actions? Does THC engender neuroadaptive changes? Are the effects of THC related to dose and frequency of use? What are the short- and long-term implications of marijuana?

Weekly sessions in the IASIC Speaker Series are free to join and the schedule is constantly expanding! For more information visit www.IASICeducation.org.

Register for this FREE Session
View Upcoming Speakers

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org.

Visit the IASIC Library here. The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top